Rotate your device

Please rotate your device to landscape mode
for the best experience.

Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tykerb 250mg Tablet

Prescription Icon
Prescription Required

Marketer

Glaxo SmithKline Pharmaceuticals Ltd

Salt Composition

Lapatinib (250mg)

Overview Tykerb 250mg Tablet

Lapatinib 250mg tablets are indicated in the management of breast cancer. Its mechanism involves inhibiting or reducing the proliferation of cancerous cells. This medication is administered either as monotherapy or in conjunction with other therapies to address advanced breast cancer. Lapatinib 250mg tablets should be ingested on an empty stomach, or at least one hour before or two hours after food consumption. Dosage and treatment length depend on disease severity and individual response. Adherence to the prescribed regimen is crucial to minimize adverse effects. Therapeutic benefits may not be immediately apparent, potentially taking weeks or months to manifest; discontinue use only under a physician's guidance. Commonly reported side effects include nausea, cephalalgia, dorsalgia, and dyspnea. Severe diarrhea may occur; increased fluid intake or medical consultation is advised if this develops. Regular blood pressure monitoring may be required. Report severe headache, cognitive impairment, visual disturbances, nausea, or emesis to your doctor immediately. Hepatic function assessment is typically performed before, during, and after treatment. Prior to commencing lapatinib therapy, inform your physician of any pre-existing hepatic or renal dysfunction. Drug interactions are possible; disclose all concurrent medications to your healthcare provider. This medication is contraindicated during gestation and lactation. Reliable contraception is essential for both partners throughout the treatment period to prevent conception.

Uses of Tykerb 250mg Tablet

Malignant breast tumor

Major Benefits of Tykerb 250mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Tykerb 250mg tablets should be taken on an empty stomach.

Common Side effects of Tykerb 250mg Tablet:

  • Abdominal pain
  • Back pain
  • Breathing problems
  • Constipation
  • Cough
  • Diarrhea
  • Fatigue
  • Headache
  • Hot flashes
  • Increased bilirubin in the blood
  • Insomnia (difficulty in sleeping)
  • Joint pain
  • Liver damage
  • Loss of appetite
  • Mucosal inflammation
  • Nausea
  • Pain in extremities
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Vomiting
  • Weakness
  • Weight gain

How to use Tykerb 250mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the 250mg Tykerb tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

How Tykerb 250mg Tablet works:

Lapatinib 250mg tablets are a cancer treatment that targets HER2 and EGFR receptors, proteins that drive excessive cell growth. By blocking these receptors, the drug prevents the signaling cascades responsible for cancer cell proliferation.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Tykerb 250mg Tablet is not definitively safe; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Lapatinib 250mg tablets pose a confirmed risk to a developing fetus and should not be used during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Lapatinib 250mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingUNSAFE

Driving ability may be impaired by the side effects of a 250mg Tykerb tablet.

KidneyKidneyCAUTION

Caution is advised when prescribing the 250mg Tykerb tablet to individuals with severe renal impairment; dosage modification may be necessary. Patients should seek medical counsel. Data regarding Tykerb 250mg tablet use in such patients is limited. Dosage alterations are not typically recommended for those with mild to moderate kidney disease.

LiverLiverCAUTION

Lapatinib 250mg tablets require careful administration in individuals with hepatic impairment. Dosage modification for lapatinib 250mg tablets may be necessary. Physician consultation is advised. Data regarding the use of this medication in patients exhibiting severe liver dysfunction is limited.

What if you forget to take Tykerb 250mg Tablet :

Omit a Tykerb 250mg Tablet dose? Seek your physician's advice.

Facts to Know About Tykerb 250mg Tablet

LabelValue
Chemical Type Quinazoline Amine Derivative
Developing Habits No.
Type of Therapy Cancer Medications
Actions TKIs
Tykerb 250mg Tablet
10,958
MRP 13,350
17% off